Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2021-07-30

Original market date: See footnote 1

2007-12-20

Lot number: See footnote 2

195221C

Expiry date: See footnote 2

2022-10-31

Product name:

DECONGEST NASAL

Description:

SPRAY

DIN:

02300265 Electronic product monograph is not available

Company:

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Nasal

Number of active ingredient(s):

1

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

52:32.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

R01AA07 XYLOMETAZOLINE

Active ingredient group (AIG) number:See footnote5

0107655001

List of active ingredient(s)
Active ingredient(s) Strength
XYLOMETAZOLINE HYDROCHLORIDE 0.1 % / W/V
Version 4.0.2
Date modified: